BioSig enters $30M ATM equity deal with Cantor; issues 950k shares for services

Streamex Corp.

Enters ATM sales agreement with Cantor Fitzgerald to sell up to $30M of common stock.
Cantor will receive 3.0% commission on gross proceeds from share sales.
Issued 950,000 unregistered shares to service providers for business development.
Offering made under effective shelf registration statement (File No. 333-251859).

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Streamex Corp. entered into Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co. (effective 2023-08-18).

Action: entry
Agreement: atm program
Counterparty: Cantor Fitzgerald & Co.
Effective: 2023-08-18

Exact text from the filing

On August 18, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Controlled Equity Offering SM Sales Agreement (the “Sales Agreement”) with Cantor Fitzgerald & Co., to act as the Company’s sales agent or principal (“Agent”), with respect to the issuance and sale of the Company’s shares of common stock

View on SEC.gov

277 material agreements filed in the last 30 days. Browse all material agreements →

Streamex Corp. filing history →

Source: SEC EDGAR

accession 0001185185-23-000873

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.